Bench-level rigor for pharmacopoeial compliance

100%

first-cycle audit pass rate

420+

compendial monographs harmonized

850+

validated chromatographic methods

<48h

out-of-specification response time

Specialized analytical disciplines

Targeted advisory covering pharmaceutical development stages from preliminary method development through regulatory submissions and commercial batch release oversight.

Analytical Method Validation

Pharmacopoeial Harmonization

GMP Quality Assurance

Protocol development under ICH Q2(R1) guidelines, establishing chromatographic resolution, linearity, limit of quantitation, and system suitability parameters for complex active ingredients.

Systematic cross-compendial alignment reconciling divergent assay criteria, impurity thresholds, and dissolution tolerances across USP, Ph. Eur., and Japanese Pharmacopoeia filings.

Defensible out-of-specification root cause triage, analytical data remediation, and laboratory audit readiness inspections aligned with FDA 21 CFR Part 211 standards.

A validation protocol must withstand an auditor's most skeptical examination. We design every assay with that exact threshold in mind.

Albanesa Technical Advisory Committee

Submit your current validation package, method transfer criteria, or out-of-specification documentation for confidential technical appraisal by senior analytical chemists.